Putative PMs from a lung cancer group in a French Caucasian population
| Sample No. | HI | S/R ratio | Sample Phenotype | CYP2C19 Genotype | |
|---|---|---|---|---|---|
| Before acidification | After acidification | ||||
| 11402 | 117.4 | 1.04 | 1.05 | PM outlier | *1 /*2 |
| 11204 | 57.9 | 1.25 | 1.11 | PM outlier | *1 /*21-a |
| 11748 | 47.7 | 1.14 | 1.02 | PM | *2 /*2 |
| 11252 | 80.4 | 0.55 | 0.75 | Probable EM (AcidS/R) | *1 /*2 |
Individuals with HI >40 from the 152 lung cancer cases from a French lung cancer/case control study. Putative PMs from controls but not lung cancer patients were previously reported (Ferguson et al. 1998). Unified allele nomenclature of Daly et al. (1996) was used.
↵1-a Reclassified as *2/*8 in this study.